GB0110578D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0110578D0
GB0110578D0 GB0110578A GB0110578A GB0110578D0 GB 0110578 D0 GB0110578 D0 GB 0110578D0 GB 0110578 A GB0110578 A GB 0110578A GB 0110578 A GB0110578 A GB 0110578A GB 0110578 D0 GB0110578 D0 GB 0110578D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0110578A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0110578A priority Critical patent/GB0110578D0/en
Publication of GB0110578D0 publication Critical patent/GB0110578D0/en
Priority to MXPA03009940A priority patent/MXPA03009940A/en
Priority to NZ528888A priority patent/NZ528888A/en
Priority to CA002445839A priority patent/CA2445839A1/en
Priority to MYPI20021593A priority patent/MY137522A/en
Priority to PL02366937A priority patent/PL366937A1/en
Priority to BR0209271-9A priority patent/BR0209271A/en
Priority to CNB028112121A priority patent/CN1302007C/en
Priority to ARP020101587A priority patent/AR033290A1/en
Priority to ES02722463T priority patent/ES2314052T3/en
Priority to HU0400070A priority patent/HUP0400070A2/en
Priority to DE60229372T priority patent/DE60229372D1/en
Priority to KR1020037014199A priority patent/KR100831534B1/en
Priority to AT02722463T priority patent/ATE411334T1/en
Priority to AU2002253342A priority patent/AU2002253342B2/en
Priority to CZ20032958A priority patent/CZ20032958A3/en
Priority to EP08157256A priority patent/EP2039700A2/en
Priority to PCT/GB2002/001971 priority patent/WO2002088167A1/en
Priority to EP02722463A priority patent/EP1383786B1/en
Priority to JP2002585465A priority patent/JP4446661B2/en
Priority to SI200230765T priority patent/SI1383786T1/en
Priority to US10/478,893 priority patent/US7291608B2/en
Priority to PT02722463T priority patent/PT1383786E/en
Priority to IL15822202A priority patent/IL158222A0/en
Priority to DK02722463T priority patent/DK1383786T3/en
Priority to ZA200308192A priority patent/ZA200308192B/en
Priority to NO20034708A priority patent/NO326015B1/en
Priority to HK04105110.0A priority patent/HK1062020A1/en
Priority to AU2007201491A priority patent/AU2007201491A1/en
Priority to US11/851,125 priority patent/US20070297989A1/en
Ceased legal-status Critical Current

Links

GB0110578A 2001-04-30 2001-04-30 Novel compounds Ceased GB0110578D0 (en)

Priority Applications (30)

Application Number Priority Date Filing Date Title
GB0110578A GB0110578D0 (en) 2001-04-30 2001-04-30 Novel compounds
DK02722463T DK1383786T3 (en) 2001-04-30 2002-04-30 Anti-inflammatory 17-beta carbothioate ester derivatives of androstan with a cyclic ester group in the 17alpha position
AU2002253342A AU2002253342B2 (en) 2001-04-30 2002-04-30 Novel anti-inflammatory androstane derivatives
EP08157256A EP2039700A2 (en) 2001-04-30 2002-04-30 Novel anti-inflammatory androstane derivatives
NZ528888A NZ528888A (en) 2001-04-30 2002-04-30 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
MYPI20021593A MY137522A (en) 2001-04-30 2002-04-30 Novel anti-inflammatory androstane derivatives.
PL02366937A PL366937A1 (en) 2001-04-30 2002-04-30 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
BR0209271-9A BR0209271A (en) 2001-04-30 2002-04-30 Compound, use of a compound pharmaceutical composition, pharmaceutical aerosol formulation, method for treating a human or animal patient with an inflammatory and / or allergic condition, and process for preparing a compound
CNB028112121A CN1302007C (en) 2001-04-30 2002-04-30 Anti-inflammatory 17. beta-carbothioate ester derivatives of androstane with a cyclic ester group in position 17. alpha
ARP020101587A AR033290A1 (en) 2001-04-30 2002-04-30 ANDROSTANO ANTIINFLAMATORY DERIVATIVES
ES02722463T ES2314052T3 (en) 2001-04-30 2002-04-30 ESTER DERIVATIVES OF 17BETA-CARBOTIOATE ANDROSTAN WITH A CYCLIC ESTER GROUP IN THE 17ALFA POSITION.
HU0400070A HUP0400070A2 (en) 2001-04-30 2002-04-30 Anti-inflammatory 17 beta-carbothioate ester derivatives of androstane with a cyclic ester group in position 17alpha, process for the preparation the compounds and pharmaceutical compositions containing them
DE60229372T DE60229372D1 (en) 2001-04-30 2002-04-30 ANTIPHLOGISTIC 7.BETA.-CARBOTHIOATES ESTER DERIVATIVES OF ANDROSTAN WITH A 17.ALPHA CYCLIC ESTER GROUP
KR1020037014199A KR100831534B1 (en) 2001-04-30 2002-04-30 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
AT02722463T ATE411334T1 (en) 2001-04-30 2002-04-30 ANTIPHLOGISTIC 7.BETA.-CARBOTHIOATE ESTER DERIVATIVES OF ANDROSTAN WITH A 17.ALPHA.-CYCLIC ESTER GROUP
MXPA03009940A MXPA03009940A (en) 2001-04-30 2002-04-30 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha.
CZ20032958A CZ20032958A3 (en) 2001-04-30 2002-04-30 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
CA002445839A CA2445839A1 (en) 2001-04-30 2002-04-30 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
PCT/GB2002/001971 WO2002088167A1 (en) 2001-04-30 2002-04-30 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
EP02722463A EP1383786B1 (en) 2001-04-30 2002-04-30 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
JP2002585465A JP4446661B2 (en) 2001-04-30 2002-04-30 Anti-inflammatory, 17β-carbothioate derivative of androstane having a cyclic ester group at the 17α position
SI200230765T SI1383786T1 (en) 2001-04-30 2002-04-30 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
US10/478,893 US7291608B2 (en) 2001-04-30 2002-04-30 Anti-inflammatory 17.β.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.α
PT02722463T PT1383786E (en) 2001-04-30 2002-04-30 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
IL15822202A IL158222A0 (en) 2001-04-30 2002-04-30 Anti-inflammatory 17. beta-carbothioate ester derivatives of androstane with a cyclic ester group in position 17. alpha
NO20034708A NO326015B1 (en) 2001-04-30 2003-10-21 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstan with a cyclic ester group at position 17.alpha and its use and preparation, as well as pharmaceutical composition and aerosol formulation
ZA200308192A ZA200308192B (en) 2001-04-30 2003-10-21 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha.
HK04105110.0A HK1062020A1 (en) 2001-04-30 2004-07-13 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
AU2007201491A AU2007201491A1 (en) 2001-04-30 2007-04-04 Novel anti-inflammatory androstane derivatives
US11/851,125 US20070297989A1 (en) 2001-04-30 2007-09-06 Novel anti-inflammatory androstane derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0110578A GB0110578D0 (en) 2001-04-30 2001-04-30 Novel compounds

Publications (1)

Publication Number Publication Date
GB0110578D0 true GB0110578D0 (en) 2001-06-20

Family

ID=9913756

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0110578A Ceased GB0110578D0 (en) 2001-04-30 2001-04-30 Novel compounds

Country Status (2)

Country Link
GB (1) GB0110578D0 (en)
ZA (1) ZA200308192B (en)

Also Published As

Publication number Publication date
ZA200308192B (en) 2005-01-21

Similar Documents

Publication Publication Date Title
GB0105895D0 (en) Novel compounds
AU2002359165A8 (en) Novel compounds
GB0106586D0 (en) Novel compounds
GB0104259D0 (en) Novel compounds
GB0102470D0 (en) Novel compounds
GB0102713D0 (en) Novel compounds
GB0103866D0 (en) Novel compounds
GB0102714D0 (en) Novel compounds
GB0100037D0 (en) Novel compounds
GB0100186D0 (en) Novel compounds
GB0100187D0 (en) Novel compounds
GB0101334D0 (en) Novel compounds
GB0101437D0 (en) Novel Compounds
GB0102469D0 (en) Novel compounds
GB0100184D0 (en) Novel compounds
GB0102570D0 (en) Novel Compounds
GB0102571D0 (en) Novel Compounds
GB0102575D0 (en) Novel Compounds
GB0102576D0 (en) Novel compounds
GB0102577D0 (en) Novel Compounds
GB0102578D0 (en) Novel Compounds
GB0102711D0 (en) Novel compounds
GB0110578D0 (en) Novel compounds
GB0100182D0 (en) Novel compounds
GB0103175D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)